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Baseball players, works of art and
rare postage stamps have value
in the market place partially as a
function of their rarity. What is it
about human nature that drives
some to chase a postage stamp
or coin, precisely because it is
rare, and others of us to crave the
stamp of approval that comes
with publishing a paper in a
prestige journal? 
It is not uncommon for
prestige-seeking journals (or at
least their editors) to flaunt their
rejection rates as evidence of
their superiority, and measures of
university ‘excellence’ often
include their selectivity. I have
been troubled for some time by
the confounding of the value of a
scientific paper with that of the
rejection rates of the journal in
which it is published (not that this
has kept me from submitting my
papers to the most competitive
journal I think will take it!). 
One can ask the simple
question: would the Watson and
Crick Nature paper describing the
structure of DNA be less
important had Nature published
twice as many other papers in the
same issue, or in the same year? I
think we would all agree that the
paper describing the structure of
DNA has intrinsic value that does
not depend on the value of the
papers that precede and follow it
in the same issue, or in the same
year. The logic that an individual
paper has more value because of
those not published next to it is
as flawed as that which accords
value to a paper because of the
number of citations to the other
papers in the journal in which it is
published.
In the ‘old days’ — good or
bad, as they may have been —
rejection rates were a necessary
outcome of page limits dictated
by financial constraints of print
publication and mailings. As we
move further into an on-lineworld, the economics of
publishing are changing, and the
need to restrict pages for
financial pressures alone is
disappearing. Indeed, future
financial incentives will favor
publishing more papers, not
fewer. Will there remain an
incentive to encode the value of a
paper merely by restricting the
number a journal publishes?
Some might argue that the time
of the reader is so precious that
we need others to signal for us
the ‘best’ papers, defined as
those published in the ‘best’
journals. In this argument, the
absence and number of the
rejected papers adds value to the
accepted papers. Certainly it
adds to their visibility, because
the other papers are not present
in the table of contents or the
printed journal. But couldn’t that
be done as easily with a gold star
such as we used to get in
kindergarten for work well done?
Already many journals have their
versions of ‘News and Views’
type editorial material, designed
to flag work thought to be of
exceptional interest. And the
success of ‘Faculty of 1000’ — an
internet service which provides
postpublication assessments of
papers judged sufficiently
interesting by members of the
‘Faculty’ — argues that there are
successful models for the field to
communicate value other than
through the rejection rate of the
journal in which a paper is
published.
Some journal editors and
publishers argue that there are
very few ‘good’ papers, and it is
their mission to keep the field
‘pure’ by not publishing inferior
work. Before going further, I must
make it clear that I believe
strongly in the value of peer
review. Many papers improve
vastly as a function of reviewers’
comments, and many technical,
logical and statistical errors are
spotted in the process.
Reviewers often point out
relevant literature that should be
cited and discussed. That said,
the review process operates best
when reviewers are asked to
think seriously about the data
and what they mean, and works
least well when reviewers areasked to judge the potential
importance of a paper. Hindsight
is 20:20, but few of us (including
reviewers and journal editors)
make reliable assessments about
the long-term value of most
papers at the time the work is
done. 
The pursuit of publication in
journals that measure value by
rejection rate (and its corollary by
Impact Factor) comes at great
cost. It is not uncommon for a
paper to have been seen by six or
eight different reviewers as it
bounces from a high profile
journal to one of lower prestige,
delaying it by months or even
years. These delays, if they are
not accompanied by
improvements in the paper, are a
violation of the social contract
we, as scientists, have with the
tax-payers who fund our work, to
publish it in a timely fashion and
make our work available to the
larger community. Sometimes the
paper improves continuously
during this process, but ironically
the least substantive reviews are
sometimes provided by reviewers
for the prestige journals, who are
often trying to justify why a paper
is or is not important, rather than
thinking about what it has
actually proven, or how it could
be improved. 
But most significantly, it sends
the terrible message to our
younger scientists that where a
paper is published matters more
than what it says. I constantly
lecture my own graduate
students and postdocs that they
should rise above such
considerations, and write
detailed, careful and scholarly
papers, and that the quality of
their papers matters more than
where they are published. Then I
do my best to help them publish
their work in the most selective
journals when we have what I
consider an important result. I
guess my philosophical principles
and logic do not make me
immune to the siren lure of honor
as defined only by the scarcity of
the opportunity to publish in
high-ranked journals. 
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